Cyted Health Enters New Growth Phase with Key Leadership Appointments#USA#Wilmington#Cyted_Health#Thomas_West#Robert_Epstein
Cyted Health Enters New Growth Phase with Key Leadership Appointments
Cyted Health has appointed Thomas West as Board Chair and Robert Epstein as Non-Executive Director to spearhead growth in the US market, enhancing their strategic leadership.
third-news.com
September 29, 2026 at 12:30 PM
Cyted Health Enters New Growth Phase with Key Leadership Appointments#USA#Wilmington#Cyted_Health#Thomas_West#Robert_Epstein
Cyted Health Lab Earns Prestigious CAP Accreditation for Excellence#USA#CAP_Accreditation#Molecular_Diagnostics#Wilmington,_Delaware#Cyted_Health
Cyted Health Lab Earns Prestigious CAP Accreditation for Excellence
Cyted Health, a leading molecular diagnostics firm, announces its US laboratory has received CAP accreditation, enhancing its commitment to esophageal disease detection.
third-news.com
April 16, 2026 at 11:08 AM
Cyted Health Lab Earns Prestigious CAP Accreditation for Excellence#USA#CAP_Accreditation#Molecular_Diagnostics#Wilmington,_Delaware#Cyted_Health
EQT Life Sciences Invests $44 Million in Cyted Health to Enhance US Market Reach#USA#Amsterdam#EQT_Life_Sciences#Cyted_Health#Series_B_Financing
EQT Life Sciences Invests $44 Million in Cyted Health to Enhance US Market Reach
EQT Life Sciences has led a $44 million Series B financing in Cyted Health, aiming to accelerate its US expansion and diagnostic innovations.
third-news.com
September 2, 2025 at 9:37 AM
EQT Life Sciences Invests $44 Million in Cyted Health to Enhance US Market Reach#USA#Amsterdam#EQT_Life_Sciences#Cyted_Health#Series_B_Financing